{"entity":{"id":"pawel-kalinski","kind":"person","name":"Pawel Kalinski","aka":[],"tldr":"Pawel Kalinski is an immunologist reprogramming tumour microenvironments so T cells can enter.","summary":"Pawel Kalinski is Vice Chair for Translational Research in the Department of Medicine and Chief of Translational Immuno-Oncology at Roswell Park Comprehensive Cancer Center. He is an immunologist known for reprogramming tumour microenvironments so that T cells can enter, developing chemokine-modulating regimens that combine interferon, TLR3 agonists and COX-2 inhibition, alongside dendritic cell vaccines. His selected paper reviews chemokine modulation to enhance T cell infiltration of tumours. He continues to work on converting immune-excluded tumours to respond to checkpoint inhibitors.","asOf":"2026-09-08","links":[{"label":"Roswell Park profile","url":"https://www.roswellpark.org/pawel-kalinski"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kalinski%20P%5BAuthor%5D"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":["checkpoint-inhibitor"],"targets":[],"drugs":[],"companies":[],"institutions":["roswell-park"],"pathways":[],"terms":["cold-vs-hot"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["cancer-immunology-research"],"dependsOn":[],"notes":[],"role":"Vice Chair for Translational Research, Department of Medicine; Chief, Translational Immuno-Oncology","institutionId":"roswell-park","specialisms":["Dendritic cell vaccines","Chemokine modulation","Tumour microenvironment"],"profiles":[{"label":"Roswell Park profile","url":"https://www.roswellpark.org/pawel-kalinski"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kalinski%20P%5BAuthor%5D"}],"papers":[{"title":"Chemokine modulation to enhance T cell infiltration of tumors","journal":"Cancer Immunology Research","year":2019}],"orcid":"0000-0001-7025-3562"},"route":"/people/pawel-kalinski/","neighbours":{"technology":[{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"}],"institution":[{"id":"roswell-park","kind":"institution","name":"Roswell Park Comprehensive Cancer Center","route":"/institutions/roswell-park/"}],"term":[{"id":"cold-vs-hot","kind":"term","name":"Hot vs cold tumours","route":"/terms/cold-vs-hot/"}],"journal":[{"id":"cancer-immunology-research","kind":"journal","name":"Cancer Immunology Research","route":"/journals/cancer-immunology-research/"}]}}